Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
210.33
Jul 06 • 04:00PM ET Dollar change-1.01 Percentage change(-0.48%)
Category
Global or ExUS Equities - Industry Sector
Sponsor
Van Eck Associates Corporation
Fund Family
Index
MVIS US Listed Biotech 25 Index
Index Weighting
Active/Passive
Expense
0.35%
Inverse/Leveraged
IPO
Dec 21, 2011
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
8.48%
SMA50
11.51%
SMA200
12.08%
Return% 1Y
36.58%
Return% 3Y
11.73%
Return% 5Y
1.74%
Return% 10Y
Return% SI
Flows% 1M
-0.02%
Flows% 3M
-1.36%
Flows% YTD
-1.75%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
25
AUM
411.37M
NAV/sh
52W High
211.34 -0.48%
52W Low
154.75 35.91%
Volatility
1.32% 1.42%
ATR (14)
3.25
RSI (14)
77.14
Beta
0.68
Rel Volume
2.37
Avg Volume
5.10K
Volume
12,089
Perf Week
4.60%
Perf Month
13.22%
Perf Quarter
12.00%
Perf Half Y
11.13%
Perf YTD
11.13%
Perf Year
33.37%
Perf 3Y
36.35%
Perf 5Y
4.71%
Perf 10Y
98.63%
Prev Close
211.34
Price
210.33
Change
-0.48%
Mar-10-26 09:24AM
06:20AM
Jan-06-26 06:20AM
Dec-19-25 08:24PM
Nov-04-25 06:20AM
06:20AM Loading…
Sep-01-25 06:20AM
Jun-30-25 06:20AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-29-25 06:20AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
12:50AM Loading…
Mar-29-25 12:50AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Dec-20-24 08:56PM
Dec-15-23 07:57PM
Apr-06-23 08:58AM
Aug-18-22 02:00PM
Jan-31-22 09:38PM
Jan-18-22 01:38PM
Jan-13-22 01:38PM
Jun-30-20 04:26PM
Jun-28-20 04:51PM
Jun-02-20 04:55PM
May-18-20 03:42PM
Feb-27-20 10:43AM
05:25PM Loading…
Feb-11-20 05:25PM
Jan-26-20 07:17PM
Dec-25-19 11:26AM
Dec-10-19 08:33AM
Dec-06-19 01:00PM
Dec-04-19 08:32AM
Dec-02-19 02:40PM
Nov-26-19 07:06PM
Nov-22-19 05:15PM
Nov-21-19 12:56PM
09:40AM
Nov-11-19 02:30PM
Nov-04-19 05:05PM
01:00PM
Sep-03-19 05:46PM
Aug-27-19 10:05AM
Aug-06-19 04:22PM
Jun-26-19 11:00AM
Jun-19-19 11:49AM
May-17-19 07:00AM
May-07-19 04:57PM
Apr-24-19 04:04PM
Apr-05-19 08:00AM
Feb-25-19 10:15AM
Feb-14-19 01:00PM
Jan-24-19 01:00PM
11:34AM
Jan-04-19 10:01AM
Nov-16-18 05:52PM
Oct-17-18 11:48AM
Aug-02-18 12:55PM
Jul-06-18 01:50PM
Jun-27-18 12:15PM
Mar-19-18 04:15PM
Jan-25-18 09:55AM
Jan-10-18 05:40PM
Jan-09-18 11:55AM
Dec-15-17 06:56PM
Nov-22-17 05:30PM
Oct-03-17 06:31AM
Sep-18-17 12:36PM
Sep-11-17 12:05PM
Sep-06-17 09:30AM
Aug-30-17 06:50PM
Aug-24-17 10:36AM
Aug-22-17 02:05PM
Aug-21-17 03:11PM
Aug-03-17 08:24AM
08:15AM
Aug-01-17 10:38AM
12:26AM
Jul-14-17 09:59AM
Jul-13-17 05:33PM
Jul-11-17 07:36AM
Jun-28-17 04:32PM
Jun-23-17 02:43PM
Jun-22-17 11:17AM
Jun-16-17 07:36AM
Jun-13-17 09:06AM
May-31-17 09:54AM
May-15-17 06:00AM
May-13-17 01:14AM
May-11-17 03:52PM
May-10-17 05:08PM
04:24PM
May-03-17 02:58PM
Apr-07-17 11:03AM
Mar-13-17 05:46PM
05:46PM
Mar-08-17 07:07AM
VanEck Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.